PD09-10 SAFETY OF AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL STEM CELLS IN ERECTILE DYSFUNCTION: AN OPEN-LABEL PHASE 1 CLINICAL TRIAL

Dalasan You,Myoung-jin Jang,Geehyun Song,Ha Chul Shin,Nayoung Suh,Yong-Man Kim,Tai Young Ahn,Choung-Soo Kim

PD09-10 SAFETY OF AUTOLOGOUS BONE MARROW DERIVED MESENCHYMAL STEM CELLS IN ERECTILE DYSFUNCTION: AN OPEN-LABEL PHASE 1 CLINICAL TRIAL

2019

Dalasan You
Myoung-jin Jang
Geehyun Song
Ha Chul Shin
Nayoung Suh
Yong-Man Kim
Tai Young Ahn
Choung-Soo Kim

INTRODUCTION AND OBJECTIVES:The efficacy of phosphodiesterase type 5 inhibitors (PDE5I), which are commonly used to treat erectile dysfunction (ED), is not satisfactory in patients with diabetes me...

Keywords:

Urology
Bone marrow
Erectile dysfunction
Phases of clinical research
Mesenchymal stem cell
Medicine
autologous bone
Diabetes mellitus
in patient
open label
Phosphodiesterase Type 5 Inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations